SCHEMBL6982392

SCHEMBL6982392

CCCC(NC(=O)[C@H]1O[C@@H]1C(=O)O)SCC(=O)N1CCN(c2ccccc2Cl)CC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HTR7 P34969 1/20 0.39
MAPT P10636 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
AR P10275 1/20 0.38
AKR1C3 P42330 1/20 0.38
TP53 P04637 1/20 0.37
ALDH1A1 P00352 4/20 0.37
RAB9A P51151 1/20 0.37
TSHR P16473 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 2/20 0.36
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984624 0.93 GRM5 (0.41) GRM5SMN1; SMN2HTR7MAPTKMT2A
SCHEMBL6981707 0.84 SMN1; SMN2 (0.43) GRM5SMN1; SMN2HTR7MAPTKMT2A
SCHEMBL6978571 0.81 KMT2A (0.44) GRM5SMN1; SMN2HTR7MAPTKMT2A
SCHEMBL6979020 0.77 SMN1; SMN2 (0.49) GRM5SMN1; SMN2KMT2AAKR1C3ALDH1A1
SCHEMBL6979028 0.77 SMN1; SMN2 (0.49) GRM5SMN1; SMN2KMT2AAKR1C3ALDH1A1
SCHEMBL6978386 0.77 KMT2A (0.49) GRM5SMN1; SMN2HTR7MAPTKMT2A
SCHEMBL6978390 0.77 KMT2A (0.49) GRM5SMN1; SMN2HTR7MAPTKMT2A
SCHEMBL6984615 0.76 KMT2A (0.51) SMN1; SMN2KMT2AAKR1C3ALDH1A1MEN1
SCHEMBL6981698 0.76 CCR1 (0.47) SMN1; SMN2KMT2ALMNAAKR1C3ALDH1A1
SCHEMBL8405526 0.75 SMN1; SMN2 (0.42) GRM5SMN1; SMN2HTR7KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771565-B1 Angiogenesis inhibitor SENJU PHARMA CO (JP) 2003-01-02 EP disclosed
US-6214800-B1 ANGIOGENESIS INHIBITORS SENJU PHARMACEUTICAL CO., LTD. (JP) 2001-04-10 US disclosed
US-6057290-A ADMINISTERING A CYSTEINE PROTEASE INHIBITOR TO A PATIENT FOR INHIBITING ANGIOGENESIS SENJU PHARMACEUTICAL CO., LTD. (JP) 2000-05-02 US disclosed
EP-0928786-A1 Angiogenesis inhibitor Senju Pharmaceutical Co., Ltd. (JP) 1999-07-14 EP disclosed
EP-0927716-A1 Angiogenesis inhibitor Senju Pharmaceutical Co., Ltd. (JP) 1999-07-07 EP disclosed
EP-0838460-A1 PIPERAZINE DERIVATIVES AND USE OF THE SAME Senju Pharmaceutical Co., Ltd. (JP) 1998-04-29 EP disclosed
EP-0771565-A2 Angiogenesis inhibitor Senju Pharmaceutical Co., Ltd. (JP) 1997-05-07 EP disclosed